Biocon Q4 results: Net profit decreased by 42% to Rs 123 crores for FY20
Biocon Q4 results: It is one of the largest biopharmaceuticals company in India located in Bangalore. However, the company manufactures generic active pharmaceutical ingredients (APIs) and sells almost 120 countries in the world. The company also manufactures novel biologics, biosimilar insulins, and antibodies.
Meanwhile, on Thursday, May 14, the company reported its Q4 results for the Financial Year 2020. The company’s standalone profit decreased by almost 42.3% to Rs 123.4 crores Year-on-Year in the quarter ended in March. The company also posted its consolidated profit of Rs 213.7 crores in the same quarter last fiscal year.
Besides, the revenue of the company from operations increased by 3% YoY to Rs 1,581 crores ended in March. The revenue of the company stood at Rs 1,528.8 crores in the same quarter last year.
On the other side, the earnings before interest, tax, depreciation, and amortization (EBITDA) of the company decreased by almost 11% to Rs 382 crores in this quarter. While the companies EBITDA stood at Rs 431 crores in the same quarter last fiscal year 2019. The companies EBITDA margin reported at 23% as against 28% Year-on-Year (YoY). Research & Development (R&D) expenditure of the company increased by 36% to Rs 125 crores as against Rs 92 crores Year-on-Year (YoY).
“We are dealing with the challenges related to COVID-19 and as a science-led company we are planning to do some spanning diagnostic tests, vaccines and therapies towards combating COVID-19, said Kiran Mazumdar-Shaw, Executive Chairman, Biocon.
On Friday, May 15, the shares of Biocon Ltd reported a bearish trend in the stock market. The company lost 10.70 points with a 3.28% decrease and reached 324.10 INR. While in BSE, the company gained 11.05 points with a 3.30% decrease and reached 324.25 INR.
Stock Market on May 15:
The early trade of both Sensex and Nifty continues its bearish trend in the stock market on Friday. The Sensex is trading below 31,000 levels, and Nifty is trading below 9,100 levels in the stock market. The Sensex lost 240.71 points with a 0.77% decrease and reached a 30,898.72 level. While Nifty lost 54.35 points with a 0.59% decrease and reached 9,088.75 level.
On the other side, the number of coronavirus cases in India reached 81,970 as of Friday, May 15, and deaths reached 2,649.
In the border market, the S&P BSE Smallcap index reported a bearish trend in the stock market on Friday. It lost 40.77 points with a 0.38% decrease and reached a 10,66555 level. The S&P BSE Midcap index lost 5053 points with a 0.44% decrease and reached an 11,486.68 level. While Nifty Bank lost 337.90 points with a 1.77% decrease and reached 18,730.60 level.
Top Gainers on May 15: BPCL, Cipla, NTPC, Tata Steel, and JSW Steel are the top gainers in today’s stock market
Top Losers on May 15: M&M, Bharti Infratel, Axis Bank, Zee Entertainment, and UPL are the top losers in today’s stock market.
